These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 28192596)

  • 1. Integrating next-generation sequencing into pediatric oncology practice: An assessment of physician confidence and understanding of clinical genomics.
    Johnson LM; Valdez JM; Quinn EA; Sykes AD; McGee RB; Nuccio R; Hines-Dowell SJ; Baker JN; Kesserwan C; Nichols KE; Mandrell BN
    Cancer; 2017 Jun; 123(12):2352-2359. PubMed ID: 28192596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creating a cancer genomics curriculum for pediatric hematology-oncology fellows: A national needs assessment.
    Murray AK; McGee RB; Mostafavi RM; Wang X; Lu Z; Valdez JM; Terao MA; Nichols KE
    Cancer Med; 2021 Mar; 10(6):2026-2034. PubMed ID: 33624449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician Experiences and Understanding of Genomic Sequencing in Oncology.
    Weipert CM; Ryan KA; Everett JN; Yashar BM; Chinnaiyan AM; Scott Roberts J; De Vries R; Zikmund-Fisher BJ; Raymond VM
    J Genet Couns; 2018 Feb; 27(1):187-196. PubMed ID: 28840409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicians' attitudes about multiplex tumor genomic testing.
    Gray SW; Hicks-Courant K; Cronin A; Rollins BJ; Weeks JC
    J Clin Oncol; 2014 May; 32(13):1317-23. PubMed ID: 24663044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician interpretation of genomic test results and treatment selection.
    Brusco LL; Wathoo C; Mills Shaw KR; Holla VR; Bailey AM; Johnson AM; Khotskaya YB; Litzenburger BC; Sanchez NS; Zeng J; Bernstam EV; Eng C; Kee BK; Amaria RN; Routbort MJ; Mills GB; Mendelsohn J; Meric-Bernstam F
    Cancer; 2018 Mar; 124(5):966-972. PubMed ID: 29165790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.
    J Clin Oncol; 1996 May; 14(5):1730-6; discussion 1737-40. PubMed ID: 8622094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor genome analysis includes germline genome: are we ready for surprises?
    Catenacci DV; Amico AL; Nielsen SM; Geynisman DM; Rambo B; Carey GB; Gulden C; Fackenthal J; Marsh RD; Kindler HL; Olopade OI
    Int J Cancer; 2015 Apr; 136(7):1559-67. PubMed ID: 25123297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
    PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing cancer genetic somatic mutation test ordering by cancer physician.
    Demeshko A; Pennisi DJ; Narayan S; Gray SW; Brown MA; McInerney-Leo AM
    J Transl Med; 2020 Nov; 18(1):431. PubMed ID: 33183308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician preferences and knowledge regarding the care of childhood cancer survivors in Japan: a mailed survey of the Japanese Society of Pediatric Oncology.
    Ishida Y; Takahashi M; Maru M; Mori M; Henderson TO; Daugherty CK; Manabe A
    Jpn J Clin Oncol; 2012 Jun; 42(6):513-21. PubMed ID: 22457322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol.
    Meric-Bernstam F; Brusco L; Daniels M; Wathoo C; Bailey AM; Strong L; Shaw K; Lu K; Qi Y; Zhao H; Lara-Guerra H; Litton J; Arun B; Eterovic AK; Aytac U; Routbort M; Subbiah V; Janku F; Davies MA; Kopetz S; Mendelsohn J; Mills GB; Chen K
    Ann Oncol; 2016 May; 27(5):795-800. PubMed ID: 26787237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing.
    Kuhlen M; Borkhardt A
    Eur J Pediatr; 2015 Aug; 174(8):987-97. PubMed ID: 25982339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of tumor genomics in clinical practice: an international survey among ASCO members.
    Barroso-Sousa R; Guo H; Srivastava P; James T; Birch W; Siu LL; Tew WP; Tolaney SM
    Future Oncol; 2019 Jul; 15(21):2463-2470. PubMed ID: 31238721
    [No Abstract]   [Full Text] [Related]  

  • 15. American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
    Robson ME; Bradbury AR; Arun B; Domchek SM; Ford JM; Hampel HL; Lipkin SM; Syngal S; Wollins DS; Lindor NM
    J Clin Oncol; 2015 Nov; 33(31):3660-7. PubMed ID: 26324357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating genetic counseling and testing in the pediatric oncology setting: Parental attitudes and influencing factors.
    Desrosiers LR; Quinn E; Cramer S; Dobek W
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27907. PubMed ID: 31294517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge, attitudes, and values among physicians working with clinical genomics: a survey of medical oncologists.
    Chow-White P; Ha D; Laskin J
    Hum Resour Health; 2017 Jun; 15(1):42. PubMed ID: 28655303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical considerations surrounding germline next-generation sequencing of children with cancer.
    Johnson LM; Hamilton KV; Valdez JM; Knapp E; Baker JN; Nichols KE
    Expert Rev Mol Diagn; 2017 May; 17(5):523-534. PubMed ID: 28399664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When Should Tumor Genomic Profiling Prompt Consideration of Germline Testing?
    DeLeonardis K; Hogan L; Cannistra SA; Rangachari D; Tung N
    J Oncol Pract; 2019 Sep; 15(9):465-473. PubMed ID: 31509718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Speaking genomics to parents offered germline testing for cancer predisposition: Use of a 2-visit consent model.
    Johnson LM; Sykes AD; Lu Z; Valdez JM; Gattuso J; Gerhardt E; Hamilton KV; Harrison LW; Hines-Dowell SJ; Jurbergs N; McGee RB; Nuccio R; Ouma AA; Pritchard M; Quinn EA; Baker JN; Mandrell BN; Nichols KE
    Cancer; 2019 Jul; 125(14):2455-2464. PubMed ID: 30901077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.